StockOtters
StockOttersSupply Chain Map
Hangzhou Tigermed Consulting Co., Ltd. logo

Hangzhou Tigermed Consulting Co., Ltd.

3347.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
858
Cost of Revenue
567
Gross Profit
291
Gross Margin
34.0%
Operating Income
86
Operating Margin
10.1%
Net Income
53
Net Margin
6.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
147
EBITDA Margin
17.1%

2023

12/31/2023

Revenue
960
Cost of Revenue
590
Gross Profit
370
Gross Margin
38.6%
Operating Income
323
Operating Margin
33.7%
Net Income
263
Net Margin
27.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
379
EBITDA Margin
39.5%

2022

12/31/2022

Revenue
921
Cost of Revenue
556
Gross Profit
365
Gross Margin
39.6%
Operating Income
336
Operating Margin
36.4%
Net Income
261
Net Margin
28.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
381
EBITDA Margin
41.4%

2021

12/31/2021

Revenue
678
Cost of Revenue
383
Gross Profit
295
Gross Margin
43.6%
Operating Income
249
Operating Margin
36.8%
Net Income
374
Net Margin
55.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
507
EBITDA Margin
74.8%

2020

12/31/2020

Revenue
415
Cost of Revenue
218
Gross Profit
197
Gross Margin
47.4%
Operating Income
146
Operating Margin
35.2%
Net Income
227
Net Margin
54.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
165
EBITDA Margin
39.7%